Artificial intelligence as a tool to increase discussions between patients and their oncology team about care goals can improve end-of-life care, according to research at led by Dana-Farber's Chris Manz, MD and presented at #ASCO22.
Dr. Manz graduated from Duke University School of Medicine in 2012. He received his training in internal medicine at the Hospital of the University of Pennsylvania from 2012-2015, and subsequently worked as a hospitalist in oncology at ...
